Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 375,656 | 342,791 | 458,441 | 451,169 | 318,166 |
| Marketable Securities | 118,268 | 177,008 | 88,614 | 59,839 | 177,813 |
| Receivables | 2,407 | 1,677 | 1,496 | 1,057 | 721 |
| TOTAL | $512,316 | $536,882 | $553,590 | $514,167 | $500,010 |
| Non-Current Assets | |||||
| PPE Net | 581 | 482 | 510 | 321 | 40 |
| Other Non-Current Assets | 5,316 | 7,514 | 10,017 | 12,052 | 169 |
| TOTAL | $5,897 | $7,996 | $10,527 | $12,373 | $209 |
| Total Assets | $518,213 | $544,878 | $564,117 | $526,540 | $500,219 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,711 | 5,143 | 3,483 | 1,838 | 3,405 |
| Accrued Expenses | 7,926 | 5,817 | 4,123 | 6,930 | 6,747 |
| TOTAL | $20,081 | $12,282 | $8,911 | $9,966 | $10,308 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,355 | 3,056 | 3,122 | 3,534 | 2,462 |
| TOTAL | $2,631 | $2,564 | $2,820 | $3,083 | $269 |
| Total Liabilities | $22,712 | $14,846 | $11,731 | $13,049 | $10,577 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 63,905 | 63,884 | 63,870 | 63,887 | 62,446 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -189,989 | -154,598 | -130,331 | -116,658 | -109,220 |
| Other shareholders' equity | 10,140 | 12,625 | 12,526 | 20,173 | 67,584 |
| TOTAL | $495,502 | $530,032 | $552,386 | $513,491 | $489,642 |
| Total Liabilities And Equity | $518,213 | $544,878 | $564,117 | $526,540 | $500,219 |